Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C

Background: An increase in the incidence of hepatocellular carcinoma (HCC) in Japan since the 1980s suggests an imminent outbreak in other countries where viral spread occurred more recently. Interferon therapy for chronic hepatitis C, in general, has been shown to prevent HCC. Aims: To determine th...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yoshida, H, Tateishi, R, Arakawa, Y, Sata, M, Fujiyama, S, Nishiguchi, S, Ishibashi, H, Yamada, G, Yokosuka, O, Shiratori, Y, Omata, M
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2004
Témata:
Liver
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773993/
https://ncbi.nlm.nih.gov/pubmed/14960528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2003.030353
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky